cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Insmed Incorporated
2 own
4 watching
Current Price
$21.59
$-0.14
(-0.64%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,628.07M
52-Week High
52-Week High
28.94
52-Week Low
52-Week Low
16.41
Average Volume
Average Volume
0.96M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,628.07M
icon52-Week High28.94
icon52-Week Low16.41
iconAverage Volume0.96M
iconDividend Yield--
iconP/E Ratio--
What does the Insmed Incorporated do?
Insmed Incorporated, a biopharmaceutical company, focuses on the development and commercialization of therapies for patients with rare diseases. The company's lead product candidate is ARIKAYCE or liposomal amikacin for inhalation, a formulation of amikacin that is in late-stage clinical development for adult patients with treatment refractory nontuberculous mycobacteria lung disease caused by Mycobacterium avium complex. It is also developing INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1, which has completed a Phase I clinical study for activating neutrophil serine proteases that are implicated in the pathology of chronic inflammatory lung diseases, such as non-cystic fibrosis bronchiectasis; and INS1009, an inhaled nanoparticle formulation of a treprostinil prodrug, which has completed a Phase I clinical study for treating rare pulmonary disorders, including pulmonary arterial hypertension. The company was founded in 1999 and is headquartered in Bridgewater, New Jersey.
Read More
How much money does Insmed Incorporated make?
News & Events about Insmed Incorporated.
PR Newswire
1day ago
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., Feb. 3, 2023 BRIDGEWATER, N.J., Feb. 3, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical...
Business Wire
9days ago
Emerald Advisers, LLC celebrated 30 years of managing client funds in 2022, and its portfolio managers and research analysts help kick off 2023 by presenting their insights and outlook for the new year at the 30th Annual Groundhog Day Investment Forum on February 2nd in King of Prussia, PA...
Ticker Report
12days ago
Insmed (NASDAQ:INSM Get Rating) had its price target cut by Barclays from $37.00 to $35.00 in a research report report published on Friday, Benzinga reports. They currently have an overweight rating on the biopharmaceutical companys stock. Other equities research analysts also ...
PR Newswire
15days ago
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., Jan. 20, 2023 BRIDGEWATER, N.J., Jan. 20, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical...
PR Newswire
29days ago
Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference PR Newswire BRIDGEWATER, N.J., Jan. 6, 2023 Topline Data from Phase 2...
Frequently Asked Questions
Frequently Asked Questions
What is Insmed Incorporated share price today?
plus_minus_icon
Can Indians buy Insmed Incorporated shares?
plus_minus_icon
How can I buy Insmed Incorporated shares from India?
plus_minus_icon
Can Fractional shares of Insmed Incorporated be purchased?
plus_minus_icon
What are the documents required to start investing in Insmed Incorporated stocks?
plus_minus_icon
What is today’s traded volume of Insmed Incorporated?
plus_minus_icon
What is today’s market capitalisation of Insmed Incorporated?
plus_minus_icon
What is the 52-Week High and Low Range of Insmed Incorporated?
plus_minus_icon
What percentage is Insmed Incorporated down from its 52-Week High?
plus_minus_icon
What percentage is Insmed Incorporated up from its 52-Week Low?
plus_minus_icon
Current Price
$21.59
$-0.14
(-0.64%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00